Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming
Jia‐Zhu Wu(Augusta University Health), Huidong Shi(Augusta University), Wei Xu(Jiangsu Province Hospital), Austin Y. Shull(Augusta University), Libin Deng(Nanchang University), Wenxun Zhong(University of Georgia), Farrukh T. Awan(The University of Texas Southwestern Medical Center), Jeong‐Hyeon Choi(Seoul National University), Xiaoling Wang(Shandong University), Jianyong Li(Jiangsu Province Hospital), Yujie Wu(Jiangsu Province Hospital), Xiaojing Xu(Augusta University), Hong‐Bo Xin(Nanchang University), Jin‐Hua Liang(Broad Institute), Eun-Joon Lee(Augusta University), Yi Miao(Jiangsu Academy of Agricultural Sciences), Lirong Pei(Augusta University), Lei Fan(Jiangsu Province Hospital)
Cited by 37
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|890
Natural selection on <i>EPAS1</i> ( <i>HIF2α</i> ) associated with low hemoglobin concentration in Tibetan highlanders
|Proceedings of the National Academy of Sciences|2010|854
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296